Search research articles
Contact Us
Filters
Showing results (301-310 of 356) with videos related to
Page
of 36
Sort By:
Journal of the National Cancer Institute
|
September 15, 2023
Prostate cancer screening in African American men: a review of the evidence
Kevin H Kensler, Roman Johnson, Faith Morley, et al.
Urologic Oncology
|
August 26, 2022
Changes in skeletal muscle and adipose tissue during cytotoxic chemotherapy for testicular germ cell carcinoma and associations with adverse events
Anthea Phuong, J Peter Marquardt, Ryan O'Malley, et al.
Nature Metabolism
|
February 16, 2021
Central and peripheral GLP-1 systems independently suppress eating
Daniel I Brierley, Marie K Holt, Arashdeep Singh, et al.
Cancer & Metabolism
|
October 20, 2023
Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition
Amy K Holt, Arafath K Najumudeen, Tracey J Collard, et al.
Urology
|
June 21, 2024
A Multicenter Evaluation of Treatment-associated Changes in Body Composition in Men With Germ Cell Tumors of the Testis: Implications for Adverse Events and Complications
Claire Buxton, Benjamin N Schmeusser, Sarah K Holt, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
January 22, 2026
Results from a prospective registry of <sup>18</sup>F-Fluciclovine PET/CT use in prostate cancer management: a cautionary lesson for implementation of PSMA PET
Steven Blinka, Risa L Wong, Sarah K Holt, et al.
Clinical Genitourinary Cancer
|
December 14, 2020
Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens
Olivia A Do, Lorin A Ferris, Sarah K Holt, et al.
Clinical Genitourinary Cancer
|
January 29, 2023
A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer
Dimitrios Makrakis, Jonathan L Wright, Martine P Roudier, et al.
The Oncologist
|
August 6, 2021
Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease
Risa L Wong, Lorin A Ferris, Olivia A Do, et al.
JCI Insight
|
May 31, 2019
Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy
Brian R Winters, Navonil De Sarkar, Sonali Arora, et al.
Page
of 36
Search research articles
Search
Showing results (301-310 of 356) with videos related to
Sort By:
Page
of 36
Journal of the National Cancer Institute
|
September 15, 2023
Prostate cancer screening in African American men: a review of the evidence
Kevin H Kensler, Roman Johnson, Faith Morley, et al.
Urologic Oncology
|
August 26, 2022
Changes in skeletal muscle and adipose tissue during cytotoxic chemotherapy for testicular germ cell carcinoma and associations with adverse events
Anthea Phuong, J Peter Marquardt, Ryan O'Malley, et al.
Nature Metabolism
|
February 16, 2021
Central and peripheral GLP-1 systems independently suppress eating
Daniel I Brierley, Marie K Holt, Arashdeep Singh, et al.
Cancer & Metabolism
|
October 20, 2023
Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition
Amy K Holt, Arafath K Najumudeen, Tracey J Collard, et al.
Urology
|
June 21, 2024
A Multicenter Evaluation of Treatment-associated Changes in Body Composition in Men With Germ Cell Tumors of the Testis: Implications for Adverse Events and Complications
Claire Buxton, Benjamin N Schmeusser, Sarah K Holt, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
January 22, 2026
Results from a prospective registry of <sup>18</sup>F-Fluciclovine PET/CT use in prostate cancer management: a cautionary lesson for implementation of PSMA PET
Steven Blinka, Risa L Wong, Sarah K Holt, et al.
Clinical Genitourinary Cancer
|
December 14, 2020
Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens
Olivia A Do, Lorin A Ferris, Sarah K Holt, et al.
Clinical Genitourinary Cancer
|
January 29, 2023
A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer
Dimitrios Makrakis, Jonathan L Wright, Martine P Roudier, et al.
The Oncologist
|
August 6, 2021
Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease
Risa L Wong, Lorin A Ferris, Olivia A Do, et al.
JCI Insight
|
May 31, 2019
Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy
Brian R Winters, Navonil De Sarkar, Sonali Arora, et al.
Page
of 36